Press Releases
03.04.2013
Life Technologies Signs License and Collaborative Stem Cell Research Agreement with Harvard University
Research collaboration aimed at yielding standardized method for evaluating iPS cell quality; deepens Life's investment to its expanding stem cell product portfolio
10.10.2012
UCB Announces Third Research Collaboration With Harvard University
New Research Alliance project to focus on human microbiome to develop new therapeutic applications in immunology
07.10.2012
CureBeta, a collaboration between Evotec and Harvard University enters strategic alliance with Janssen Pharmaceuticals
The CureBeta initiative was established by Harvard, the Howard Hughes Medical Institute, and Evotec in 2011 to leverage the assets and expertise in industry and academia to identify and develop disease-state modifying therapeutic targets.
07.09.2012
Boehringer Ingelheim establishes translational research collaboration with Harvard University
The goal of the collaboration is for the scientists of Boehringer Ingelheim to work together with the scientific community of Harvard to advance our knowledge in areas of high unmet medical need.
06.30.2011
UCB Launches Research Alliance with Harvard University
Alliance creates a unique drug discovery bridge between industry and academia, with Harvard scientists continuing their research that holds potential for the development of new therapeutic modalities in clinical medicine.
03.10.2011
Evotec Establishes Research Collaboration With Harvard University and the Howard Hughes Medical Institute in Diabetes Research
Collaboration Established to Drive Innovation and Develop New Diabetes Therapies Targeting Beta Cell Regeneration
02.28.2011
UCB Establishes Innovative Collaboration with Harvard University
Research Alliance Formed to Drive Innovation and Develop New Therapies in Areas of High Patient Need
12.20.2010
Technology Development Accelerator Fund Proves Boon to Research With Commercial Potential
Harvard University’s Proof-of-Concept Program Speeds Development of New Technologies, Builds Bridges to Industry, Keeps Pace with US Innovation Agenda
10.18.2010
Sanofi-aventis Establishes Research Collaboration with Harvard University
Sanofi-aventis announced today a research collaboration with Harvard University. The goal of the collaboration is to advance knowledge in the area of human health through basic and applied research and to promote scientific exchange between Harvard University and sanofi-aventis. The focus of this collaboration is translational biomedical research in multiple therapeutic areas such as cancer, diabetes and inflammation.
08.26.2010
GnuBio Acquires Exclusive World Wide Rights to Novel Microfluidics and Emulsion Methodologies for DNA Sequencing
Harvard-based startup granted exclusive worldwide license to scalable, low cost, emulsion based DNA Sequencing methodologies
08.09.2010
Introducing MedNetworks: New Venture Based on Social Network Analytic Technology Developed at Harvard University
MedNetworks, Inc. today launched as a new venture based on the social network analytics research of professor Nicholas Christakis of Harvard University. Christakis is a physician and social scientist internationally renowned for his groundbreaking research on social factors influencing health.
03.08.2010
Harvard University and Dana-Farber Cancer Institute Grant Acetylon Exclusive License to Breakthrough Discovery Platform for Next Generation HDAC Inhibitors
Harvard University and Dana-Farber Cancer Institute announced today that they have concluded a major licensing agreement with Acetylon under which Harvard and Dana-Farber granted an exclusive therapeutic license to a robust platform technology and chemical methodology that enables high-throughput screening and lead optimization for HDAC inhibitor compounds.
02.23.2010
Harvard University Grants Exclusive Licensing Rights For Breakthrough Diagnostic Technologies to Diagnostics For All
Harvard University and Diagnostics For All, Inc. (DFA) today announced an agreement under which Harvard granted DFA exclusive rights to certain diagnostics technologies developed in the laboratories of Professor George Whitesides, the Woodford L. and Ann A. Flowers University Professor at Harvard University
12.08.2009
Harvard University Announces Major Collaboration to Advance Pioneering Stem Cell Research
Harvard University today announced that its Office of Technology Development
has concluded a large-scale multi-year sponsored research agreement with Novartis Institutes for Biomedical Research to advance an innovative line of research focused on the use of stem cells for drug discovery.
11.09.2009
Six Universities Adopt New Technology Transfer Principles Designed to Speed Access to Affordable Medicines in The Developing World
A consortium of six leading research universities and the
Association of University Technology Managers (AUTM) today announced their endorsement of a far-reaching “Statement of Principles and Strategies for the Equitable Dissemination of Medical Technologies” in the developing world.
09.23.2009
Harvard’s Technology Development Accelerator Fund Announces 2009 Awards
=Biomedical Seed Fund Speeds Development of Emerging Technologies=
07.07.2009
SpacedEd Launches Innovative Learning Technology Licensed from Harvard University
Spaced Education, Inc. has signed an exclusive license agreement with Harvard University for a new learning technology that was developed and used at Harvard Medical School.
04.23.2009
Nanosys, Inc. Signs Two Cooperation Agreements with Harvard University
The agreements will combine intellectual property assets covering fundamental nanowire technology to address non-volatile memory and biosensors.
12.15.2008
Harvard University and Nanosys License Nanowire Biosensor Systems To Vista Therapeutics
Vista has secured the exclusive, worldwide rights for the use of nanowires for the detection of biomarkers associated with organ or tissue damage
10.14.2008
Harvard University's Innovative Opinion Technology Licensed to Crimson Hexagon
New Technology Provides Accurate, Automated Opinion Analysis for Blogs, Communities, and Social Media
10.13.2008
Harvard University and SiOnyx Partner to Commercialize Black Silicon
Harvard Spinout Obtains Exclusive Rights to University’s Portfolio of Black Silicon Patents, Aims to Revolutionize Photonics
06.17.2008
Harvard University and Not-for-Profit, Diagnostics-For-All, Partner to Introduce Innovative, Low-Cost Diagnostic Technology in the Developing World
Agreement reinforces Harvard’s commitment to global health and access to its innovative technologies
06.12.2008
Harvard and SunEthanol, Inc. Announce Collaboration to Advance Biofuels Research
Pioneer in genetic engineering to lead effort to improve ethanol yield from biomass
04.09.2008
Harvard Announces Pioneering Collaboration with Merck & Co., Inc. to Advance Osteoporosis Research
Research on bone formation could potentially pave the way to new therapies
10.24.2007
BASF and Harvard University announce extensive research collaboration to drive new frontiers of innovation and knowledge
Partners establish the BASF Advanced Research Initiative at Harvard University
06.06.2007
Harvard University’s Office of Technology Development and Medicine in Need (MEND)
Sign Licensing Agreement to Help Bring New Vaccines and Drugs to Developing Countries
06.04.2007
Harvard Licenses Broad Portfolio of Nanotechnologies to Nano-Terra
Patents will Enable Commercialization of Pioneering Work of Prof. George Whitesides Across a Broad Range of Industries
05.24.2007
Harvard University’s Office of Technology Development and
DAISO Sign Co-Exclusive Licensing Agreement
Hydrolytic Kinetic Resolution (HKR) for Chiral Intermediates Synthes
05.22.2007
Harvard Office of Technology Development and Carl Zeiss MicroImaging GmbH Sign Licensing Agreement for CARS Microscopy Technology
Technology Being Developed to Expand the Power of Optical Microscopes, Enhancing Scientists’ Ability to Image Molecules in Living Cells and Organisms
05.14.2007
Harvard Office of Technology Development and Leica Microsystems Sign Licensing Agreement for CARS Microscopy Technology
Technology Being Developed to Expand the Power of Optical Microscopes, Enhancing Scientists’ Ability to Image Molecules in Living Cells and Organisms
03.27.2007
Harvard University’s Office of Technology Development and Rohm and Haas Electronic Materials Sign License Agreement for Atomic Layer Deposition Technology
Breakthrough Technology to Improve the Manufacturing of Next Generation Semiconductor Chips
03.06.2007
Harvard Joins Effort To Protect Public Interest In Technology Licensing Process
11.24.2006
TetraPhase Pharmaceuticals Formed to Advance Breakthrough, Harvard-Developed Synthesis Technology for New Antibiotics to Treat Drug-Resistant Bacterial Infections
Company Completes $25M Series A Financing